• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

ACT:US

226.5900 USD 0.2800 0.12%

As of 18:40:02 ET on 08/28/2014.

Company Profile for Actavis plc (ACT)

Actavis plc manufactures specialty pharmaceuticals. The Company develops, manufactures and distributes generic, brand and over-the-counter products. Actavis offers its pharmaceutical drugs around the world.

Contact Information

Actavis plc

Morris Corporate Center III
400 Interpace Parkway
Parsippany, NJ 07054
United States
Phone: 1-862-261-7000

Key Executives for Actavis plc (ACT)

Paul M BisaroChairmanBrenton L Saunders "Brent"President/CEO
R Todd JoyceChief Financial OfficerRobert A Stewart "Bob"Chief Operating Officer
James C D'AreccaChief Accounting OfficerCharles M MayrChief Communications Ofcr:Global
Patrick J EaganChief Human Resources Ofcr:GlobalWilliam Meury "Bill"Exec VP:Commercial
Lisa M DefrancescoVP:Global Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil